Biopharma Digital Infrastructure, Compute & Software Market
完整報告名稱與涵蓋範圍
Biopharma Digital Infrastructure, Compute & Software Market Size, Share & Trends Analysis Report, By Component (High-Performance Computing and AI Accelerator Infrastructure, Cloud Platforms and Scientific Data Storage, Scientific Software, Informatics and Data Management Platforms, Integration, Managed Services and Digital Transformation Services), By Deployment (Public Cloud, On-Premise and Private Cloud, Hybrid and Sovereign), By Application (Drug Discovery, Computational Biology and AI Model Training, Clinical Development and Real-World Data Analytics, Manufacturing, Quality and Supply Chain Digitalization, Commercial, Regulatory and Enterprise Operations), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The biopharma digital infrastructure, compute and software market covers high-performance computing and AI accelerator infrastructure, cloud platforms and scientific data storage, scientific software, informatics and data management platforms and integration and managed services deployed by pharmaceutical and biotechnology companies, contract research and manufacturing organisations and research institutions for discovery, clinical development, manufacturing and enterprise operations. Laboratory instruments, AI drug discovery platforms sold as partnered programs and clinical trial systems addressed in separate InsightAce studies are excluded from double counting.
Investment is driven by the computational intensity of AI-driven discovery, protein structure and generative models, by the volume of genomic, imaging and real-world data, by regulatory expectations for data integrity and by enterprise programs that modernise legacy systems across research, clinical and manufacturing. Pharmaceutical companies are building GPU clusters and partnering with cloud providers and hardware vendors on dedicated AI infrastructure, adopting cloud-native scientific data platforms and unifying informatics across sites, while sovereignty and security requirements sustain hybrid architectures. Cost of compute, data governance, talent, vendor consolidation and the balance between owned and cloud capacity shape spending patterns.
North America and Europe lead spending, with Asia Pacific growing through Chinese, Japanese, Korean and Singaporean biopharmaceutical investment. Competition involves AI compute and server vendors, hyperscalers, life sciences software specialists and systems integrators.
The InsightAce study supplies US$ forecasts for all component, deployment, application and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biopharma Digital Infrastructure, Compute & Software Market Snapshot
Chapter 4. Global Biopharma Digital Infrastructure, Compute & Software Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Component Estimates & Trend Analysis
5.1. Component & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Component:
5.2.1. High-Performance Computing and AI Accelerator Infrastructure
5.2.2. Cloud Platforms and Scientific Data Storage
5.2.3. Scientific Software, Informatics and Data Management Platforms
5.2.4. Integration, Managed Services and Digital Transformation Services
Chapter 6. Market Segmentation 2: By Deployment Estimates & Trend Analysis
6.1. Deployment & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Deployment:
6.2.1. Public Cloud
6.2.2. On-Premise and Private Cloud
6.2.3. Hybrid and Sovereign
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Drug Discovery, Computational Biology and AI Model Training
7.2.2. Clinical Development and Real-World Data Analytics
7.2.3. Manufacturing, Quality and Supply Chain Digitalization
7.2.4. Commercial, Regulatory and Enterprise Operations
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Large Pharmaceutical Companies
8.2.2. Biotechnology Companies
8.2.3. CROs, CDMOs and Research Institutions
Chapter 9. Biopharma Digital Infrastructure, Compute & Software Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. NVIDIA Corporation
11.2. Dell Technologies Inc.
11.3. Hewlett Packard Enterprise Company
11.4. Lenovo Group Limited
11.5. Intel Corporation
11.6. Advanced Micro Devices, Inc.
11.7. Super Micro Computer, Inc.
11.8. IBM Corporation
11.9. Amazon Web Services, Inc.
11.10. Microsoft Corporation
11.11. Google Cloud
11.12. Veeva Systems Inc.
11.13. Benchling, Inc.
11.14. Dassault Systemes SE (BIOVIA, Medidata)
11.15. Accenture plc
圖表清單 List of Tables & Figures
Table 1. Global Biopharma Digital Infrastructure, Compute & Software Market Revenue Forecast by Component, 2026-2035 (US$ Mn)
Figure 1. Global Biopharma Digital Infrastructure, Compute & Software Market Segmentation and Scope Overview
Table 2. Global Biopharma Digital Infrastructure, Compute & Software Market Revenue Forecast by Deployment, 2026-2035 (US$ Mn)
Figure 2. Global Biopharma Digital Infrastructure, Compute & Software Market Share by Component, 2026 & 2035
Table 3. Global Biopharma Digital Infrastructure, Compute & Software Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Biopharma Digital Infrastructure Stack from AI Compute to Scientific Data and Applications
Table 4. Global Biopharma Digital Infrastructure, Compute & Software Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. AI-Driven Discovery and Data Growth Driving Compute and Platform Investment, 2026-2035
Table 5. Global Biopharma Digital Infrastructure, Compute & Software Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Biopharma Digital Infrastructure, Compute & Software Growth Opportunity Analysis
Table 6. North America Biopharma Digital Infrastructure, Compute & Software Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Biopharma Digital Infrastructure, Compute & Software Market Participants
Table 7. Europe Biopharma Digital Infrastructure, Compute & Software Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Biopharma Digital Infrastructure, Compute & Software Market
Table 8. Asia Pacific Biopharma Digital Infrastructure, Compute & Software Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Owned, Cloud and Hybrid Infrastructure Strategies Among Pharmaceutical Companies
Table 9. Strategic Developments of Leading Biopharma Digital Infrastructure, Compute & Software Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們